Lupkynis Capsule
Product Images NDC 75626-001

3 FDA label images from Aurinia Pharma U.s., Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lupkynis (NDC 75626-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurinia Pharma U.s., Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem (Chemical Structure01)

Chem (Chemical Structure01)
Chemical structure of the active ingredient voclosporin, a complex cyclic peptide molecule, as depicted in the image.*
FDA Label Image

Wallet Artwork (Wallet Artwork 2025)

Wallet Artwork (Wallet Artwork 2025)
Packaging label for LUPKYNIS (voclosporin) capsules 7.9 mg, an oral human prescription drug by Aurinia Pharma U.S., Inc. The label shows a carton with 60 capsules (4 blister packs of 15 capsules each). It includes dosage strength, product name, and manufacturer details, along with warnings and contact information for medication questions and side effects reporting.*
FDA Label Image

Carton (Carton Artwork 2025)

Carton (Carton Artwork 2025)
Packaging label for Lupkynis (voclosporin) capsules 7.9 mg by Aurinia Pharma U.S., Inc. The label indicates 180 capsules (3 wallets of 60 capsules each) for oral use only and states storage instructions, dosage recommendations, and contact information. It includes the Aurinia logo and the product NDC code 75626-001.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.